S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ATHA Athira Pharma Inc

1.96

0.00 (0.00%)

May 03 2024 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Athira Pharma Charts.

Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Athira Pharma Charts.

Athira Pharma Inc News

Athira Pharma to Participate in Upcoming May Conferences
Thursday 2 May 2024 (3 days ago) • GlobeNewswire Inc.

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
Wednesday 3 April 2024 (1 month ago) • GlobeNewswire Inc.

Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

More Athira Pharma Inc News Articles

Voip Pal Com (QB)

Code Green Apparel (PK)

Kraig Biocraft Laborator... (QB)

TheGlobe com (PK)

Northwest Biotherapeutics (QB)

Cann American (CE)

Lightwave Logic

Digital Brand Media and ... (PK)

Rennova Health (PK)

Anavex Life Sciences

Trump Media and Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions